Catalent Gosselies

Active

Public limited companyfounded 201114 yrs activeRue Auguste Piccard 37, 6041 Charleroi, BelgiumKBO/BCE: BE 0840.843.708

Summary

Catalent Gosselies has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-131.04M) and a net result of €-183.18M. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 64 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.2% (low).

Watch Print / PDF

Checked score

Score 2025

23 / 100

Critical

The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability0=

Solvency0▼-54

Growth24▼-32

Track record100

Bankruptcy probability, 12 months

1.2% Low

0%0.5%1.5%4%10%≥ 25%

No credit on open account

Liquidity short (current ratio 0.04 against 1.58 in 2024; short-term debt: 583.4% and cash: 1.1% of total assets), and equity is negative.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Eight signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Multiple establishment units

Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.

KBO · establishment units

Annual accounts: weaker financial profile

The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

-540.7%

Return on assets

-755.9%

Age of the figures

9 mo

Lower-risk legal form

Companies with this legal form statistically fail less often than a BV.

KBO · legal form

Long track record

A company with a long track record statistically fails less often than a young one.

KBO · incorporation date

Age against the risk zone

Higher-failure-rate sector

In this sector companies fail more often than the Belgian average.

Gazette · bankruptcies per sector, NACE 21

Relative position

BE, all sectors

reference

Sector 21

higher

← fewer bankruptcies more bankruptcies →

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Negative equity

The 2025 annual accounts show negative equity and a net loss.

NBB · annual accounts 2025

Equity per financial year

1819202122232425

2018 to 2025 · latest year €-131.04M

Filed after the deadline

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-08-2026, 14 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

NBB · 10 filings

Deviation from the deadline

2025

14 d late

2024

34 d late

2023

57 d late

2022

41 d early

2021

11 d early

2020

74 d early

2019

43 d early

← before the deadline after the deadline →

Checked, nothing found (1)

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover

€10.04M▼ 63.3%

2024 · €27.34M

2018: €17.35M 2019: €27.78M 2020: €15.73M 2021: €35.92M 2022: €50.70M 2023: €32.69M 2024: €27.34M

2018 → 2025

EBIT margin

-1152.3%▼ 1068.3pp

2024 · -84.0%

2018: 23.0% 2019: -1.4% 2020: 6.0% 2021: -16.9% 2022: -12.2% 2023: -74.4% 2024: -84.0%

2018 → 2025

Net result

€-183.18M▼ 473%

2024 · €-31.96M

2018: €3.71M 2019: €-438k 2020: €947k 2021: €-6.68M 2022: €-9.21M 2023: €-29.46M 2024: €-31.96M

2018 → 2025

Working capital

€-135.99M

2024 · €8.14M

2018: €2.49M 2019: €5.35M 2020: €1.27M 2021: €-8.41M 2022: €-34.29M 2023: €-104.08M 2024: €8.14M

2018 → 2025

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line20212022202320242025Trend

Turnover€35.92M-€50.70M▲ 41.2%€32.69M▼ 35.5%€27.34M▼ 16.4%€10.04M▼ 63.3%

Equity€7.97M-€-1.46M€-31.10M▼ 2,037%€53.74M€-131.04M

Operating result€-6.08M-€-6.17M▼ 1.5%€-24.32M▼ 294%€-22.97M▲ 5.6%€-115.71M▼ 404%

Net result€-6.68M-€-9.21M▼ 37.9%€-29.46M▼ 220%€-31.96M▼ 8.5%€-183.18M▼ 473%

Result per fiscal year

Operating resultNet result

The operating result stays negative: a loss of €115.71M in 2025 against €22.97M in 2024; the loss grows and 2025 has the lowest result in the available series.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €24.23M

77.8%

22.2%

Fixed assets €18.85M ▼ 88.3%

Current assets €5.39M ▼ 75.8%

Key figures and ratios

2025 value · change against 2024

EBITDA

€-110.80M▼

2024 · €-19.09M

Cash flow

€-178.27M▼

2024 · €-28.07M

Solvency

-540.7%▼

2024 · 29.3%

Current ratio

0.04▼

2024 · 1.58

Quick ratio

0.04▼

2024 · 1.52

Debt to equity

-1.08▼

2024 · 2.42

ROA

-755.9%▼

2024 · -17.4%

Interest coverage

-13.59▼

2024 · -2.08

Debt

€141.40M▲

2024 · €129.87M

Debt ≤ 1 year

€141.38M▲

2024 · €14.11M

Income taxes

€20k▼

2024 · €35k

Staff costs

€26.97M▼

2024 · €27.05M

Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Filed annual accounts As filed with the NBB · 2025 against 2024 · 87 lines

Balance sheet Code20242025

Assets

Total assets20/58€183.61M€24.23M▼

Fixed assets21/28€161.36M€18.85M▼

Intangible fixed assets21€4.99M€4k▼

Tangible fixed assets22/27€94.08M€16.06M▼

Land and buildings22€21.49M€13.90M▼

Plant, machinery and equipment23€1.04M€553k▼

Furniture and vehicles24€243k€1.13M▲

Leasing and similar rights25€396k€0▼

Other tangible fixed assets26€28k€0▼

Assets under construction and advance payments27€70.89M€475k▼

Financial fixed assets28€62.29M€2.78M▼

Affiliated companies280/1€62.16M€2.65M▼

Participating interests280€62.16M€2.65M▼

Other financial fixed assets284/8€126k€127k▲

Amounts receivable and cash guarantees285/8€126k€127k▲

Current assets29/58€22.25M€5.39M▼

Amounts receivable after more than one year29€297k€285k▼

Trade receivables290-€285k

Other amounts receivable291€297k-

Stocks and contracts in progress3€762k€254k▼

Stocks30/36€762k€254k▼

Goods purchased for resale34€762k€254k▼

Amounts receivable within one year40/41€16.56M€3.66M▼

Trade receivables40€14.55M€3.66M▼

Other amounts receivable41€2.01M-

Cash at bank and in hand54/58€1.14M€264k▼

Deferred charges and accrued income490/1€3.49M€923k▼

Equity and liabilities

Total equity and liabilities10/49€183.61M€24.23M▼

Equity10/15€53.74M€-131.04M▼

Contributions10/11€122.56M€122.56M=

Capital10€122.56M€122.56M=

Issued capital100€122.56M€122.56M=

Reserves13€626k€626k=

Non-distributable reserves130/1€353k€353k=

Legal reserve130€353k€353k=

Distributable reserves133€273k€273k=

Profit (loss) carried forward14€-71.04M€-254.22M▼

Investment grants15€1.59M€0▼

Provisions and deferred taxes16-€13.87M

Provisions for liabilities and charges160/5-€13.87M

Other liabilities and charges164/5-€13.87M

Amounts payable17/49€129.87M€141.40M▲

Amounts payable after more than one year17€112.65M-

Financial debts170/4€112.65M-

Other loans174€112.65M-

Amounts payable within one year42/48€14.11M€141.38M▲

Current portion of amounts payable after more than one year42€154k€547k▲

Trade debts44€5.60M€907k▼

Suppliers440/4€5.60M€907k▼

Advances received on contracts in progress46€2.39M€234k▼

Taxes, remuneration and social security45€4.56M€2.47M▼

Taxes450/3€589k€616k▲

Remuneration and social security454/9€3.97M€1.86M▼

Other amounts payable47/48€1.40M€137.22M▲

Accrued charges and deferred income492/3€3.12M€20k▼

Income statement Code20242025

Operating income70/76A€33.86M€28.15M▼

Turnover70€27.34M€10.04M▼

Change in stocks of work in progress, finished goods and contracts in progress71€-292k-

Other operating income74€6.81M€16.28M▲

Non-recurring operating income76A-€1.82M

Operating charges60/66A€56.82M€143.86M▲

Goods for resale, raw materials and consumables60€8.48M€2.95M▼

Purchases600/8€7.90M€2.53M▼

Change in stocks: decrease (increase)609€578k€416k▼

Services and other goods61€15.23M€13.05M▼

Remuneration, social security and pensions62€27.05M€26.97M▼

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3.88M€4.91M▲

Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€1.96M€491k▼

Other operating charges640/8€210k€510k▲

Non-recurring operating charges66A-€94.98M

Operating profit (loss)9901€-22.97M€-115.71M▼

Financial income75/76B€270k€301k▲

Recurring financial income75€270k€301k▲

Other financial income752/9€270k€301k▲

Financial charges65/66B€9.22M€67.76M▲

Recurring financial charges65€9.22M€8.25M▼

Debt charges650€9.16M€8.15M▼

Other financial charges652/9€60k€94k▲

Non-recurring financial charges66B-€59.51M

Profit (loss) for the period before taxes9903€-31.92M€-183.16M▼

Income taxes67/77€35k€20k▼

Taxes670/3€35k€20k▼

Profit (loss) for the period9904€-31.96M€-183.18M▼

Profit (loss) for the period to be appropriated9905€-31.96M€-183.18M▼

Appropriation of the result

Profit (loss) to be appropriated9906€-71.04M€-254.22M▼

Profit (loss) brought forward from the previous period14P€-39.08M€-71.04M▼

Social balance

Average headcount (FTE)9087229.6146.5▼

The notes to these accounts (84 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 59Financial 4Gazette 45Filings 10

2026

14-08

NBB filing Annual accounts filed

fiscal year 2025 · full schema · 14 days late

04-08

State Gazette act Resignation: Herbert Maurice Donaldson (director)

2 facts ▸

General meeting, 20/01/2026
Director resignation, Herbert Maurice Donaldson (director)

09-01

State Gazette act Resignation: Léonard Sinave (director)

Appointment: Wim Blendeman (director)3 facts ▸

General meeting, 22/12/2025
Director resignation, Léonard Sinave (director)
Director appointment, Wim Blendeman (director)

2025

31-12

Financial Weakest financial yearnet €-183.18M

Net result drops to €-183.18M, the lowest in the series.

24-10

State Gazette act Registered office

Registered-office move2 facts ▸

Board meeting
Registered-office move, Rue Auguste Piccard 37, 6041 Charleroi (Gosselies)

05-06

State Gazette act Appointments: MCERLANE David Patrick (director) and DONALDSON Herbert Maurice (director)

Statutes amendment · Officer mandate change8 facts ▸

General meeting, 27/05/2025
Statutes amendment
Statutes amendment
Statutes amendment
Director appointment, MCERLANE David Patrick (director)
Director appointment, DONALDSON Herbert Maurice (director)
Officer mandate change, Ramon Ceron
Officer mandate change, Sarah Hauer

19-03

State Gazette act Resignation: Delara MOTLAGH (director)

Appointment: Sarah Hauer (director) · Director discharge · Mandate compensation6 facts ▸

General meeting, 05/02/2025
General meeting, 11/02/2025
Director resignation, Delara MOTLAGH (director)
Director discharge, Delara MOTLAGH
Director appointment, Sarah Hauer (director)
Mandate compensation, Sarah Hauer

06-03

NBB filing Annual accounts filed

fiscal year 2024 · full schema · 34 days late

2024

02-07

State Gazette act Capital & shares · Statutes amendment

Capital increase · Capital · Statutes amendment4 facts ▸

General meeting, 25/06/2024
Capital increase, €117.000.000
Capital, €122.558.168,89
Statutes amendment

30-06

Financial Liquidity times 7current ratio 1.58

Current ratio from 0.22 to 1.58; short-term debt falls from €132.87M to €14.11M.

30-06

Financial Equity above €50MEq €53.74M

Equity rises from €-31.10M to €53.74M.

21-06

State Gazette act Appointments: EY Réviseurs d'Entreprises SRL (statutory auditor) and Grant Thornton (statutory auditor)

Permanent representatives: Thomas Meurice and Aman Kuderbux5 facts ▸

Shareholder decision, 04/06/2024
Auditor appointment, EY Réviseurs d'Entreprises SRL (statutory auditor)
Auditor appointment, Grant Thornton (statutory auditor)
Permanent representative, Thomas Meurice
Permanent representative, Aman Kuderbux

Show earlier events

28-03

NBB filing Annual accounts filed

fiscal year 2023 · full schema · 57 days late

19-03

State Gazette act Resignation: Frédéric Duquesnel (daily management delegate)

2 facts ▸

Board meeting, 26/02/2024
Director resignation, Frédéric Duquesnel (daily management delegate)

19-03

State Gazette act Appointment: EY Réviseurs d'Entreprises SRL (statutory auditor)

Permanent representative: Thomas Meurice3 facts ▸

General meeting, 29 février 2024
Auditor appointment, EY Réviseurs d'Entreprises SRL (statutory auditor)
Permanent representative, Thomas Meurice

02-02

State Gazette act Permanent representative: Thomas Meurice

2 facts ▸

Board meeting, 29/12/2023
Permanent representative, Thomas Meurice

2023

28-12

State Gazette act Resignation: Luca Russo (daily management delegate)

2 facts ▸

Board meeting, 12/12/2023
Director resignation, Luca Russo (daily management delegate)

30-10

State Gazette act Resignations: Steven Fasman (director) and Luca Russo (director)

Appointments: Léonard Sinave (director) and Ramon Ceron (director) · Director discharge · Mandate compensation9 facts ▸

General meeting, 02/10/2023
Director resignation, Steven Fasman (director)
Director resignation, Luca Russo (director)
Director discharge, Steven Fasman (director)
Director discharge, Luca Russo (director)
Director appointment, Léonard Sinave (director)
Director appointment, Ramon Ceron (director)
Mandate compensation, Léonard Sinave
Mandate compensation, Ramon Ceron

13-07

State Gazette act Resignations: Manja Boerman (director) and Jonathan Arnold (director)

Appointments: Luca Russo (director) and Delara Motlagh (director) · Director discharge · Mandate compensation9 facts ▸

General meeting, 21/06/2023
Director resignation, Manja Boerman (director)
Director discharge, Manja Boerman
Director resignation, Jonathan Arnold (director)
Director discharge, Jonathan Arnold
Director appointment, Luca Russo (director)
Director appointment, Delara Motlagh (director)
Mandate compensation, Luca Russo
Mandate compensation, Delara Motlagh

2022

21-12

NBB filing Annual accounts filed

fiscal year 2022 · full schema

16-12

State Gazette act Appointment: Frédéric Duquesnel (daily management delegate)

Director resignation3 facts ▸

Board meeting, 01/12/2022
Director appointment, Frédéric Duquesnel (daily management delegate)
Director resignation

14-12

State Gazette act Resignation: Karen Flynn (director)

Appointment: Jonathan Arnold (director) · Director discharge · Mandate compensation5 facts ▸

General meeting, 30/11/2022
Director resignation, Karen Flynn (director)
Director discharge, Karen Flynn (director)
Director appointment, Jonathan Arnold (director)
Mandate compensation, Jonathan Arnold

16-03

State Gazette act Appointment: Luca Russo (daily management delegate)

2 facts ▸

Board meeting, 18/02/2022
Director appointment, Luca Russo (daily management delegate)

20-01

NBB filing Annual accounts filed

fiscal year 2021 · full schema

04-01

State Gazette act Restructuring

Merger · Accounting effect3 facts ▸

General meeting, 13/12/2021
Merger, absorption, 13/12/2021
Accounting effect, 01/07/2021

04-01

State Gazette act Restructuring

Merger · Accounting effect4 facts ▸

General meeting, 13/12/2021
Merger
Merger
Accounting effect, 01/07/2021

2021

09-11

State Gazette act Restructuring · Miscellaneous

Merger · Accounting effect · Power of attorney8 facts ▸

Merger
Merger
Merger
Accounting effect, 01/07/2021
Power of attorney, Freshfields Bruckhaus Deringer LLP
Power of attorney, Freshfields Bruckhaus Deringer LLP
Power of attorney, Freshfields Bruckhaus Deringer LLP
Power of attorney, Freshfields Bruckhaus Deringer LLP

28-10

State Gazette act Resignation: Patrick Stragier (director)

Director discharge4 facts ▸

Written resolution, 06/10/2021
Director resignation, Patrick Stragier (director)
Director resignation, Patrick Stragier (daily management delegate)
Director discharge, Patrick Stragier

14-07

State Gazette act Resignation: Charles Jacques (director)

Reappointment: Patrick Stragier (director) · Director discharge · Mandate compensation6 facts ▸

General meeting, 07/05/2021
Director resignation, Charles Jacques (director)
Director discharge, Charles Jacques
Director reappointment, Patrick Stragier (director)
Mandate compensation, Patrick Stragier
Power of attorney, Freshfields Bruckhaus Deringer LLP

25-06

State Gazette act Miscellaneous

Statutes amendment2 facts ▸

General meeting, 10/06/2021
Statutes amendment

22-06

State Gazette act Appointment: SRL EY Réviseurs d'Entreprises (statutory auditor)

Permanent representative: Erc Van Hoof3 facts ▸

General meeting, 02/02/2021
Auditor appointment, SRL EY Réviseurs d'Entreprises
Permanent representative, Erc Van Hoof

30-03

State Gazette act Appointments: Charles Jacques (director) and Patrick Stragier (director)

Mandate compensation5 facts ▸

General meeting, 15 et 16 février 2021
Director appointment, Charles Jacques (director)
Director appointment, Patrick Stragier (director)
Mandate compensation, Charles Jacques
Mandate compensation, Patrick Stragier

2020

18-11

NBB filing Annual accounts filed

fiscal year 2020 · full schema

13-08

State Gazette act Appointments: Manja Boerman (chair of the board) and Patrick Stragier (daily management delegate)

Resignation: Denis Bedoret (toutes ses fonctions au sein du conseil d'administration)4 facts ▸

Board meeting, 17/06/2020
Director appointment, Manja Boerman (chair of the board)
Director resignation, Denis Bedoret (toutes ses fonctions au sein du conseil d'administration)
Director appointment, Patrick Stragier (daily management delegate)

06-07

State Gazette act Statutes amendment · Resignations & appointments

Name change · Statutes amendment · Capital7 facts ▸

General meeting, 26/06/2020
Name change, Catalent Gosselies
Statutes amendment
Statutes amendment
Statutes amendment
Capital, €5.558.168,89
Registered-office move, Rue Auguste Piccard 48, 6041 Charleroi

30-06

Financial Back to profitnet €947k

Net result €947k after one loss-making year.

18-06

NBB filing Annual accounts filed

fiscal year 2019 · full schema

24-03

State Gazette act Resignations: Vered Caplan, Shimon Chassine and 3 others

Appointments: Karen Flynn, Manja Boerman and Steven Fasman · Mandate compensation12 facts ▸

General meeting, 21/02/2020
Director resignation, Vered Caplan (director)
Director resignation, Shimon Chassine (director)
Director resignation, Noah Rhodes (director)
Director resignation, Jean-Paul Prieels (director)
Director resignation, Jean Smal (director)
Director appointment, Karen Flynn (director)
Director appointment, Manja Boerman (director)
Director appointment, Steven Fasman (director)
Mandate compensation, Karen Flynn
Mandate compensation, Manja Boerman
Mandate compensation, Steven Fasman

2019

26-08

State Gazette act Resignation: Ohad Karnieli (director)

Appointment: Noah Rhodes (director)3 facts ▸

General meeting, 18/04/2019
Director resignation, Ohad Karnieli (director)
Director appointment, Noah Rhodes (director)

17-05

NBB filing Annual accounts filed

fiscal year 2018 · full schema

11-01

State Gazette act Appointment: SCCRL PwC Réviseurs d'Entreprises (statutory auditor)

Permanent representative: Romain Seffer · Director discharge4 facts ▸

General meeting, 19/04/2018
Director discharge, MASTHERCELL
Auditor appointment, SCCRL PwC Réviseurs d'Entreprises (statutory auditor)
Permanent representative, Romain Seffer

2018

25-10

State Gazette act Appointment: Denis Bedoret (managing director)

2 facts ▸

Board meeting, 12/09/2018
Director appointment, Denis Bedoret (managing director)

24-10

State Gazette act Resignation: Hugues Bultot (director)

2 facts ▸

Board meeting, 30/04/2018
Director resignation, Hugues Bultot (director)

23-05

NBB filing Annual accounts filed

fiscal year 2017 · full schema

2017

13-12

State Gazette act Appointments: Jean-Paul Prieels (director) and Jean Smal (independent director)

Capital increase · Capital · Statutes amendment8 facts ▸

General meeting, 15/11/2017
Capital increase, €1.070.000
Capital increase, €3.930.000
Capital, €5.558.168,89
Statutes amendment
Director appointment, Jean-Paul Prieels (director)
Director appointment, Jean Smal (independent director)
Power of attorney, Sophie Maquet

27-10

NBB filing Annual accounts filed

fiscal year 2016 · full schema · 88 days late

28-07

State Gazette act Appointment: Denis Bedoret (daily management delegate)

2 facts ▸

Board meeting, 06/07/2017
Director appointment, Denis Bedoret (daily management delegate)

12-06

State Gazette act Capital & shares

Capital increase · Capital decrease · Capital7 facts ▸

General meeting, 22/05/2017
Capital increase, €910.313,69
Capital increase, €100.000
Capital decrease, €8.858.234,8
Capital, €558.168,89
Statutes amendment
Power of attorney, Hugues BULTOT

02-05

State Gazette act Resignations: Marie Bouillez SPRL (director) and Françoise Magerman (director)

Permanent representative: Marie Bouillez4 facts ▸

General meeting, 24/02/2017
Director resignation, Marie Bouillez SPRL (director)
Permanent representative, Marie Bouillez
Director resignation, Françoise Magerman (director)

22-03

State Gazette act Resignations: MAGERMAN Françoise (director) and MARIE BOUILLEZ SPRL (director)

Appointment: Ohad Karnieli (director) · Statutes amendment · Power of attorney6 facts ▸

General meeting, 06/03/2017
Statutes amendment
Director resignation, MAGERMAN Françoise (director)
Director resignation, MARIE BOUILLEZ SPRL (director)
Director appointment, Ohad Karnieli (director)
Power of attorney, Conseil d'administration

2016

24-03

State Gazette act Resignation: Chris BUYSE (director)

Appointment: Françoise MAGERMAN (director)3 facts ▸

General meeting
Director resignation, Chris BUYSE (director)
Director appointment, Françoise MAGERMAN (director)

2015

29-12

State Gazette act Capital & shares

Capital increase · Capital · Statutes amendment4 facts ▸

General meeting, 10/12/2015
Capital increase, €6.006.090
Capital, €8.406.090
Statutes amendment

08-12

State Gazette act Appointment: PricewaterhouseCoopers/PwC Reviseurs d'entreprises scrl (réviseur de l'entreprise)

Permanent representative: Romain Seffer · Director discharge4 facts ▸

Director discharge, MASTHERCELL
Director discharge, MASTHERCELL
Auditor appointment, PricewaterhouseCoopers/PwC Reviseurs d'entreprises scrl (réviseur de l'entreprise)
Permanent representative, Romain Seffer

26-03

State Gazette act Resignations: BULTOT Hugues Pierre Ghislain, BOUILLEZ Marie Nicole Astrid and 3 others

Appointments: CAPLAN Vered, CHASSINE Shimon and 3 others · Registered-office move · Capital15 facts ▸

General meeting, 03/03/2015
Registered-office move, Rue Auguste Piccard, 48
Capital, €2.400.000
Statutes amendment
Statutes amendment
Director resignation, BULTOT Hugues Pierre Ghislain (director)
Director resignation, BOUILLEZ Marie Nicole Astrid (director)
Director resignation, MAGERMAN Françoise (director)
Director resignation, PRIEELS Jean Paul Hubert Philippe (director)
Director resignation, CASTILLO FERNANDEZ Jose Antonio (director)
Director appointment, CAPLAN Vered (director)
Director appointment, CHASSINE Shimon (director)
+3 further facts in this act

2014

05-12

State Gazette act Resignation: Patrick STRAGIER (director)

Appointment: Hugues BULTOT (managing director)3 facts ▸

General meeting, 20/08/2014
Director resignation, Patrick STRAGIER (director)
Director appointment, Hugues BULTOT (managing director)

12-11

State Gazette act Capital & shares

Capital increase · Capital · Bond issuance4 facts ▸

General meeting, 18/09/2014
Capital increase, €250.000
Capital, €2.400.000
Bond issuance, convertible, 1.600

31-07

State Gazette act Registered office · Resignations & appointments

Registered-office move · Power of attorney · Director resignation5 facts ▸

Board meeting, 12/02/2014
Registered-office move, Rue Auguste Piccard 48, 6041 Gosselies
Power of attorney, Lesage
Director resignation
Director appointment

2013

16-12

State Gazette act Capital & shares · Statutes amendment

Bond issue · Capital increase · Power of attorney7 facts ▸

General meeting, 13/11/2013
Bond issue, Emission d'un emprunt obligataire privé convertible pour un montant de 250.000 EUR représenté par 250 obligations d'une valeur nominale de 1.000 euros
Capital increase
Power of attorney, deux administrateurs agissant conjointement
Bond interest, 4.5%
Bond duration, 10 years, maturing on 12/11/2023
Conversion ratio, 1 bond converts to 1 share of category A

2011

18-11

State Gazette act Incorporation

Appointments: Marie BOUILLEZ, José CASTILLO and 3 others · Founder · Founding capital13 facts ▸

Incorporation, 04/11/2011
Founder, CELL THERAPY HOLDING
Founder, Université Libre de Bruxelles
Founding capital, €2.150.000
Bank account, ING BELGIQUE, 363-0962655-67
Director appointment, Marie BOUILLEZ (director)
Director appointment, José CASTILLO (director)
Director appointment, Patrick STRAGIER (director)
Director appointment, Jean-Paul PRIEELS (director)
Director appointment, Françoise MAGERMAN (director)
Director appointment, Jean-Paul PRIEELS (daily management delegate)
Director appointment, José CASTILLO (chair of the board)
+1 further facts in this act

Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

5 directors, no change since 2026

Wim Blendeman

Director · since 01-01-2026

Current

David Patrick McErlane

Director · since 27-05-2025

Current

Sarah Hauer

Director · since 11-02-2025

Current

Ramon Ceron

Director · since 02-10-2023

Current

José CASTILLO

Director · since 04-11-2011

Not recently confirmed

20-01-2026 Herbert Maurice Donaldson: Resigned as Director

01-01-2026 Wim Blendeman: Appointed as Director

31-12-2025 Léonard Sinave: Resigned as Director

27-05-2025 David Patrick McErlane: Appointed as Director

27-05-2025 Herbert Maurice Donaldson: Appointed as Director

Full history in the Timeline (70 changes) →

Location & real-estate footprint

Registered office, Charleroi · 3 establishment units since 2011

establishment approximate All 3 establishment units on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rue Auguste Piccard 376041 Charleroi

Ground area

3.0 ha

Building footprint

5,932 m²

Volume, LiDAR

12,567 m³

2 parcels, Wallonia · tallest building 18.8 m, ±5 floors. Linked by address, not a title deed.

3 establishment units

Rue Auguste Piccard 48, 6041 Charleroi

Manufacture of basic pharmaceutical products and pharmaceutical preparations

since 20112.226.485.441

Rue Louis Bleriot 41, 6041 Charleroi

Manufacture of basic pharmaceutical products and pharmaceutical preparations

since 20202.308.517.549

Rue Auguste Piccard 37, 6041 Charleroi

Manufacture of basic pharmaceutical products and pharmaceutical preparations

since 20212.346.965.775

2 parcels

Wallonia 2 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
52028B0298/00A002	Wallonia	2.1 ha	1 · 5,141 m²	-
52028B0323/00M003	Wallonia	8,679 m²	1 · 791 m²	18.8 m · 5 fl.

Linked by address, not proof of ownership

Methodology

via registered seat: 1 · via establishment units: 1

2 of 2 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Statutory auditor

2 auditors

EY Réviseurs d'Entreprises SRLCurrent Statutory auditor · represented by Thomas Meurice	19-03-2024 → present
Grant ThorntonCurrent Statutory auditor · represented by Aman Kuderbux	21-06-2024 → present

Show 3 earlier auditors

Ernst et Young Reviseurs d'Entreprises Auditor · represented by Erc Van Hoof succeeded by EY Réviseurs d'Entreprises SRL in 2024	22-06-2021 → 19-03-2024
PricewaterhouseCoopers (PwC) Reviseurs d'Entreprises SCRL Réviseur de l'entreprise · represented by Romain Seffer succeeded by SCCRL PwC Réviseurs d'Entreprises in 2019	08-12-2015 → 11-01-2019
SCCRL PwC Réviseurs d'Entreprises Statutory auditor · represented by Romain Seffer succeeded by Ernst et Young Reviseurs d'Entreprises in 2021	11-01-2019 → 22-06-2021

Articles of association

Purpose

Le développement et la commercialisation d’un système de production de cellules à activité thérapeutique pour compte de tiers, selon la réglementation ATMP 1394/2007, orienté…

Full purpose

Le développement et la commercialisation d’un système de production de cellules à activité thérapeutique pour compte de tiers, selon la réglementation ATMP 1394/2007, orienté qualité/technologie/client, comprenant (i) des salles blanches et un laboratoire de contrôle qualité à la pointe du progrès et de la traçabilité, (ii) une équipe d’experts en thérapie cellulaire empreints d’excellence opérationnelle et (iii) un réseau collaboratif avec des partenaires stratégiques.

according to the deed of 06-07-2020

Structure & network

Connections & network

19 connected companies

Shared directors

Linked via shared directors

CATALENT GOSSELIES HOLDING

via David Patrick McErlane · Director

→

Catalent Gosselies PS

via David Patrick McErlane · Director

→

Advanced Coatings & Construction Solutions

Shared director

→

ASCENCIO MANAGEMENT

Shared director

→

Show 15 more companies with a shared director

BePharBel Manufacturing

Shared director

→

BIOPOLE ULB - CHARLEROI en abrégé BUC

Shared director

→

BioSenic

Shared director

→

Celyad Oncology

Shared director

→

Epicentre-espace de santé inclusive

Shared director

→

Fluvius System Operator

Shared director

→

Fondation Francqui

Shared director

→

Fund+

Shared director

→

GlaxoSmithKline Biologicals

Shared director

→

iTeos Belgium

Shared director

→

PIENTER-JAN

Shared director

→

SOFIA

Shared director

→

ULB GENERAL PARTNER

Shared director

→

VLAAMSE ENERGIEHOLDING

Shared director

→

RLE INVEST

Shared corporate director

→

Acquisitions and mergers

3 transactions

Took over:HEPATIC CELL THERAPY SUPPORT SA

BE 0841.727.891State Gazette act of 04-01-2022 (2 acts)

Took over:SKELETAL CELL THERAPY SUPPORT SA

BE 0841.570.812State Gazette act of 04-01-2022 (2 acts)

Took over:SOCIETE D'INFRASTRUCTURES, DE SERVICES ET D'ENERGIES

BE 0841.727.101merger by absorption · State Gazette act of 04-01-2022 (2 acts)

Capital and shareholders

Shareholders according to the acts

At incorporation act of 18-11-2011 ↗

CELL THERAPY HOLDING (BE 0840.625.061) 1,400 shares (65.1%)
Université Libre de Bruxelles 750 shares (34.9%)

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years

02-07-2024 Capital increase of 117,000,000 EUR · to 122,558,168.89 EUR · 83,968 new shares
06-07-2020 Capital stated in the act · 5,558,168.89 EUR · 3,989 shares
13-12-2017 Capital increase of 1,070,000 EUR · to 1,628,168.89 EUR · 142 new shares
13-12-2017 Capital increase of 3,930,000 EUR · to 5,558,168.89 EUR · 523 new shares
12-06-2017 Capital increase of 910,313.69 EUR · to 9,316,403.69 EUR · 117 new shares · in kind
12-06-2017 Capital increase of 100,000 EUR · to 9,416,403.69 EUR · 36 new shares · conversion d'obligations convertibles existantes
12-06-2017 Capital reduction of 8,858,234.80 EUR · to 558,168.89 EUR · to absorb losses
29-12-2015 Capital increase of 6,006,090 EUR · to 8,406,090 EUR · 771 new shares · in cash

Show 3 older capital entries

26-03-2015 Capital stated in the act · 2,400,000 EUR · 2,400 shares
12-11-2014 Capital increase of 250,000 EUR · to 2,400,000 EUR
18-11-2011 Incorporation · 2,150,000 EUR · 2,150 shares

Recognitions · licences · registrations

Legal Entity Identifier

875500U0QNXJDRPNLR24

live in the LEI register

Similar companies · same sector, comparable size

MECS EUROPE/AFRICA

BE 0875.005.128

Hoeilaart · Eq €36.53M

PolyPeptide

BE 0879.346.768

Braine-l'Alleud · Eq €96.61M

TELIX INNOVATIONS

BE 0627.636.718

Herstal · Eq €116.66M

Prothya Biosolutions Belgium

Sint-Lambrechts-Woluwe · Eq €22.33M

Of 148 companies in sector 21100 we hold annual accounts for 108. 13 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification

Legal formPublic limited company

Founded07-11-2011

Fiscal year end31-12

Activities, NACEBEL 2025

21100Manufacture of basic pharmaceutical products and pharmaceutical preparations

21209Manufacture of basic pharmaceutical products and pharmaceutical preparations

Sources

Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.